NSD2 and neoplasm: Targeted CRISPR-mediated deletion of WHSC1 in colon cancer cells has been shown to inhibit the growth of tumor cells, enhance sensitivity to treatment medications, and significantly reduce the tumor cells’ capacity to spread (27, 30).